Rilonacept in Subjects With Cardiac Sarcoidosis (NCT06660732)
A RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins University — Baltimore, Maryland
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Johns Hopkins University — Baltimore, Maryland
- Mayo Clinic in Rochester — Rochester, Minnesota
📞 Contact the Study Coordinator
Phone: (507) 255-2029
Email: Johnson.Lezlie@mayo.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiac Sarcoidosis
- A Trial of Baricitinib in Patients With Cardiac Sarcoidosis — Palo Alto, California
- Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression — Philadelphia, Pennsylvania
- Cardiac Sarcoidosis Multi-Center Prospective Cohort — Calgary, Alberta
- Repurposing Tilmanocept for Cardiac Sarcoidosis — Durham, North Carolina
- Cardiac Sarcoidosis Randomized Trial — New Haven, Connecticut
- Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS) — Rochester, Minnesota
Explore by condition: All Cardiac Sarcoidosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.